Patent Assignment
Reel/Frame 068529/0381
Change of Name
Recorded: 2024-09-09
Pages: 5
Assignor
HEPTARES THERAPEUTICS LIMITED
Executed: 2024-04-01
Assignee
NXERA PHARMA UK LIMITED
GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CB21 6DG, UNITED KINGDOM
Covered Properties
(5)
Muscarinic Receptor Agonists
Pharmaceutical Compounds
Application:
62/408,468 →
Oxime Compounds as Agonists of the Muscarinic M1 and/or M4 Receptor
Quinolinone and Benzoxazine Derivatives as Muscarinic M1 and/or M4 Receptor Agonists
Pharmaceutical Composition for the Treatment of Alzheimer's Disease or Dementia
Application:
18/280,611 →
Publication:
US 2024/0165097
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 13, 2016
From: BROWN, GILES ALBERT; CONGREVE, MILES STUART; PICKWORTH, MARK; TEHAN, BENJAMIN GERALD
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 040908/0264 →
Assignment of Assignor's Interest
Jul 28, 2021
From: CONGREVE, MILES STUART; BROWN, GILES ALBERT; TEHAN, BENJAMIN GERALD; PICKWORTH, MARK
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 057011/0149 →
Assignment of Assignor's Interest
Aug 13, 2021
From: BROWN, GILES ALBERT; CONGREVE, MILES STUART; TEHAN, BENJAMIN GERALD; PICKWORTH, MARK
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 057173/0913 →
Assignment of Assignor's Interest
Jan 29, 2022
From: BROWN, GILES ALBERT; TEHAN, BENJAMIN GERALD
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 058818/0029 →
Assignment of Assignor's Interest
Oct 27, 2023
From: TASKER, TIM
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 065366/0507 →
Assignment of Assignor's Interest
Nov 3, 2023
From: HEPTARES THERAPEUTICS LIMITED
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED; HEPTARES THERAPEUTICS LIMITED
Reel/Frame 065453/0194 →